<html>
  <div class="bg-white p-6 rounded-md shadow-md">
    <h2 class="text-lg font-bold mb-4">Clinical Efficacy of Oncozen</h2>
    <p class="text-gray-600 mb-6">Oncozen has demonstrated a robust safety profile in clinical trials, making it a reliable treatment option for patients with [specific type of cancer].</p>
    <div class="flex flex-wrap justify-center mb-6">
      <div class="w-full md:w-1/2 xl:w-1/3 p-4">
        <h3 class="text-lg font-bold mb-2">Objective Response Rate (ORR)</h3>
        <p class="text-gray-600">In a Phase III clinical trial, Oncozen showed an ORR of [percentage]%, with [number]% of patients achieving a complete response.</p>
      </div>
      <div class="w-full md:w-1/2 xl:w-1/3 p-4">
        <h3 class="text-lg font-bold mb-2">Progression-Free Survival (PFS)</h3>
        <p class="text-gray-600">Oncozen demonstrated a median PFS of [timeframe], significantly improving treatment outcomes for patients with [specific type of cancer].</p>
      </div>
      <div class="w-full md:w-1/2 xl:w-1/3 p-4">
        <h3 class="text-lg font-bold mb-2">Safety Profile</h3>
        <p class="text-gray-600">Oncozen was well-tolerated, with a low incidence of grade 3/4 adverse events (<[percentage]%) and no unexpected safety signals.</p>
      </div>
    </div>
    <p class="text-gray-600 mb-4">These results demonstrate the clinical efficacy of Oncozen, while also highlighting its robust safety profile.</p>
    <a href="#" class="inline-block bg-orange-500 hover:bg-orange-700 text-white font-bold py-2 px-4 rounded">Learn more about Oncozen's clinical trials</a>
  </div>
</html>